Background and objectives: Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic progressive joint inflammation with subsequent cartilage destruction. This study was conducted to evaluate and compare the effect of bone marrow mesenchymal stem cells (BM-MSCs) versus Methotrexate (MTX) on knee joint in a rat model of RA. Materials and Methods: Thirty-five adult male albino rats were divided into two groups. Group I: control group (15 rats). Group II (20 rats) in which RA was induced, and then the rats were subdivided into four subgroups. Subgroups IIa and IIb were sacrificed two and four weeks after induction of RA respectively. Subgroups IIc and IId were treated by MTX and BM-MSCs respectively after two weeks of induction of RA and were sacrificed after further two weeks. The knee joints were collected, decalcified and processed for histological, histochemical, immunehistochemical and morphometric studies. Results: Histological examination of the knee joints revealed that RA resulted in thickening of the intimal lining of the synovial membrane, infiltration, congestion and increased collagen content of the subintima. The articular cartilage showed erosions, thinning, cell and ground substance loss and increased expression of inducible nitric oxide synthase (iNOS). Injection of BM-MSCs resulted in improvement of the structure of the synovial membrane and the articular cartilage of the knee joint whereas, injection of MTX was relatively less effective. Conclusion: Intra-articular injection of BM-MSCs resulted in a significant improvement in the histological structure of the knee joint in comparison to MTX in a rat model of RA.
INTRODUCTION
Rheumatoid arthritis (RA) is a chronic, poly-articular, inflammatory and destructive autoimmune disease that does not result from a single factor or single environmental exposure. Yet, the pathophysiology of the disease requires combination of genetic and non-genetic factors as hormonal and environmental factors [1] .
The disease is characterized by chronic progressive joint inflammation with subsequent cartilage and bone destruction. Rheumatoid arthritis could be either primary that occurs alone or secondary that occurs in association with other autoimmune disease as lupus, interstitial lung disease and vasculitis [2] .
Currently, there is no optimal therapy for RA except for systemic immune-suppressants which have serious side effects. One of these is Methotrexate which is a commonly used drug in the treatment of RA. Despite its efficacy, it is not well tolerated by most patients because of its serious adverse effects [3] .
The need for other treatment modalities has emerged in an attempt to develop a treating agent that is effective as MTX but devoid of its serious side effects. One of these recently tried methods is the use of mesenchymal stem cells as they were found to differentiate into variety of mesenchymal tissue as bone, cartilage, muscle and adipose tissue [4] .
Several studies suggested that BM-MSCs might have ameliorative effect on joint destruction with induction of cartilage regeneration [5 -7] . On the contrary, other studies proposed that BM-MSCs had little therapeutic role in the treatment of RA induced in rats especially when administrated at the late stage of the disease [8, 9] .
One of the most widely used arthritis models is a single injection of complete Freund′s adjuvant (CFA) which is formed of a mixture of paraffin oils, mannide monooleate, and heat-killed mycobacteria [10] .
The purpose of this study was to explore and compare the effect of MTX and MSCs on the histological structure of the knee joint in a rat model of RA.
MATERIALS AND METHODS

Animal groups
The experiment included 35 adult Wister male albino rats (weighing 150 -200 gm). Animals were purchased from and housed in Medical Research Center (MASRI), Faculty of Medicine, Ain Shams university. The animals were kept in wire mesh cages and were allowed a free access to standard chow diet and tap water. All the experimental procedures were performed in accordance with guidelines of scientific research ethics committee of Faculty of Medicine, Ain Shams University.
Experimental animals were randomly divided into two main groups:
Group I (Control group, n=15), further subdivided into four subgroups corresponding to the experimental subgroups. Subgroup Ia (n=3), negative control group. Subgroup Ib (RA control, n=6), received a single subcutaneous injection of 0.3 ml normal saline (solvent of CFA) in the metatarsal footpad of right hind limb using insulin syringe. Three rats were sacrificed after two weeks and another three rats after four weeks. Subgroup Ic (MTX control, n=3), received normal saline in the same dose and route as subgroup Ib. After two weeks, another twice weekly subcutaneous injections of 0.3 ml saline (dilute of MTX) was given for further 2 weeks then sacrificed and Subgroup Id (BM-MSCs control, n=3), received normal saline in the same dose and route as subgroup Ib. After two weeks, a single intra-articular injection of 0.25 ml phosphate buffered saline (the vehicle of stem cell) in the left knee joint was given then the rats were sacrificed after further two weeks.
Group II (Experimental group, n= 20), RA was induced using a single subcutaneous injection of 0.1ml of CFA (Sigma-Aldrich, USA) suspended in 0.2 normal saline in the metatarsal footpad of right hind limb [11] . Animals of this group were further subdivided into four equal subgroups (5 animals each):
Subgroup IIa: Rats were sacrificed after two weeks from the injection of CFA to confirm induction of RA (early RA). Subgroup IIb: Rats were sacrificed after four weeks from injection of CFA (late RA). Subgroup IIc (MTX treated group): Rats were left for two weeks after injection of CFA, then received twice weekly subcutaneous injection of 0.3mg/ kg MTX (Sandoz Swiss Company) for another two weeks, then sacrificed [12] ; and Subgroup IId (BM-MSCs treated group): Rats were left for two weeks after injection of CFA, then received single intra-articular injection of PKH26 labeled MSCs in the left knee joint in a concentration of 2×10 6 , then sacrificed after further two weeks.
Histological studies
At the end of the experiment, all animals were sacrificed after ether inhalation anesthesia. Left knee joints were dissected, trimmed of skin and muscles and were fixed in a solution of 5.5gm ethylene-diamine-tetra-acetic acid (EDTA) dissolved in 90 ml distilled water and 10 ml formaldehyde. Daily change of the solution was done for six weeks until softening of specimens was obtained. Then specimens were dehydrated, cleared, embedded in paraffin and cut into serial sections of 5 µm thickness then stained with different histological stains (H&E and Masson's trichrome) [13] , histochemical stains (Safranin O) for cartilage matrix [13] and immunehistochemical avidine-biotin peroxidase technique for detection of a proinflammatory cytokine; inducible nitric oxide synthase (iNOS) [14] . To confirm the specificity of immune staining, the primary antibody was replaced with heat attenuated normal rat serum (negative control). Another two cartilage sections from subgroup IIb were stained with the substrate solution with or without the inhibitor of alkaline phosphatase to exclude the possibility of nonspecific labeling.
Culture of BM-MSCs (15)
The isolated BM-MSCs were cultured in complete culture medium (Dulbecco's modified Eagle's medium "DMEM", Sigma Aldrich, USA) supplemented with 1% penicillinstreptomycin in sterile tissue culture dishes and incubated in a standard air/CO2 incubator at 37°C. Mesechymal stem cells were distinguished from other bone marrow cells by their tendency to adhere to the tissue culture flasks and dishes (Figs. 1a,1b) .
On reaching more than 75% confluence (Fig. 1c) subculture was performed by washing cells with PBS (1 or 2 times), followed by addition of 2.5 ml of Trypsin-EDTA for 5minutes at 37°C inside the incubator. The action of Trypsin-EDTA was stopped by complete culture medium and the detached cells suspension was spinned down at 15002000-RPM for 10 minutes. The cells in the precipitated cell pellet were counted and tested for viability using haemocytometer.
Characterizations of the cultured BM-MSCs
On day five of the primary culture two petri dishes were spared and prepared for characterized of BM-MSCs using immune-histochemical staining for CD44 [16] (Fig. 1d ).
Fluorescence labeling of stem cells by PKH26 dye for in vivo tracking of BM-MSCs
Labeling of stem cells was done after the third passage as described by the supplier (Sigma-Aldrich, Catalog Numbers MINI26, MIDI26 and PKH26GL). For testing viability of PKH26-labeled primary BM-MSCs, they were re-cultured. Fluorescent microscope examination of cartilage specimens of rats treated with the labeled cells (subgroup IId) was done to insure their incorporation into tissues (Fig. 1e) .
N.B. Isolation, culturing and labeling of stem cells were done at Biochemistry department, Faculty of Medicine, Cairo University.
Morphometric measurements:
The following parameters were measured in randomly chosen five fields/section, in five sections for every rat in each subgroup, at a constant magnification for each parameter.
The cartilage thickness in micrometers (μm) in H&E stained sections, the staining density of the cartilage matrix in Safranin O stained sections, the number of iNOS positive chondrocytes (cells/μm 2 ) in immunohistochemically stained sections and area percentage of collagen fibers in the synovial membrane in Masson's trichrome stained sections.
All measurements were performed using Leica microscope DM 2500 connected to a camera (Leica DFC 295) and Leica Q win V3 image analysis software (Leica microsystems, Germany) at image analysis unit, Histology and Cell Biology Department, Faculty of Medicine, Ain Shams University.
Statistical analysis
All values of the morphometric results were expressed as mean ± standard deviation (SD). Statistical analysis was carried out using Statistical Package for Social Sciences (SPSS), software program, version 20 (IBM Corporation, Armonk, New York, USA). Statistical difference among groups was determined using two-way analysis of variance (ANOVA) followed by post hoc least significance difference (LSD) for comparison between more than two groups. P values < 0.05 were considered statistically significant.
RESULTS:
Light microscopic results:
Sections of the control subgroups stained with H&E showed almost similar histological structure. The articular cartilage surface was smooth, the chondrocytes were arranged into zones; Superficial tangential zone; in which chondrocytes were arranged with their longitudinal axis parallel to the articular surface, middle zone; in which chondrocytes were rounded and scattered, and deep zone; in which chondrocytes were arranged into parallel columns perpendicular to the articular surface. Tidemarks appeared as transverse lines separating the deep cartilage zone from the underlying calcified zone (Fig.2a) .
In subgroup IIa (early RA), the articular surface was irregular with scattered erosions. Some lacunae appeared empty while others showed shrunken chondrocytes with pyknotic nuclei. Some areas showed loss of chondrocytes and fissuring of the cartilage matrix. Multiple scattered isogenous cell groups were also observed (Fig 2b) . In subgroup IIb (late RA), marked irregularities of the articular surface with frequent surface erosions and areas of chondrocytes' loss were observed. The middle zone showed discontinuity of the matrix, large empty lacunae and degenerated shrunken chondrocyte with pyknotic nuclei. Many scattered isogenous cell groups were detected. Apparent thinning of the articular cartilage was also noticed with ill-defined tidemark (Fig.2c) .
In subgroup IIc (MTX treated), the articular surface was regular and smooth. The cartilage matrix was continuous. Chondrocytes appeared occupying their lacunar spaces and were grouped in clusters or isogenous groups, although they were poorly organized into layers compared to the control group. The tidemark was evident (Fig. 2d) .
In subgroup IId (MSCs treated), the articular surface was smooth. Chondrocyte appeared occupying their lacunar spaces. The cartilage matrix was intact, and chondrocytes were almost organized into layers comparable to the control group. (Fig 2e) .
As regards the synovial membrane, the control group demonstrated thin intimal lining formed of one to two layers of synovial cells. The subintimal stroma was formed of adipose connective tissue with few scattered thin walled blood vessels (Fig 3a) . Few scattered collagen fibers in the subintimal stroma of the synovial membrane was seen in Masson's trichrome stained sections (Figs 4a).
Subgroup IIa (early RA), showed thickening of the intimal lining, and the subintimal stroma showed inflammatory cells, and dilated congested blood vessels (Fig 3b) with an apparent increase in the collagen fiber content in comparison to the control group (Fig 4b) . In subgroup IIb (late RA), the intimal lining showed marked thickening with villous formation. Subintimal stroma showed inflammatory cells infiltration and congested blood vessels (Fig 3c) and an apparent increase in the collagen fiber content in the subintimal stroma (Fig4c).
Subgroup IIc (MTX treated), demonstrated relatively thin lining of the intima and the subintimal stroma showed few scattered inflammatory cells, and some congested dilated blood vessels (Fig 3d) and an apparent decrease in the collagen fiber content was noticed in the subintimal stroma as compared to subgroups IIa and IIb (Fig4d).
Subgroup IId (MSCs treated), showed relatively thin intimal lining with minimal inflammatory cells (Fig. 3e) . Apparent few scattered collagen fibers in the subintimal stroma was noticed as compared to the other experimental subgroups (Fig. 4e) .
Safranin O stain of the control group showed homogenous orange color of the ground substance of the articular cartilage (Fig. 5a ).
In subgroups IIa and IIb (early & late RA), apparent decrease in the intensity of Safranin O stain as compared to the control (Figs. 5b and 5c respectively) was noticed.
In subgroups IIc and IId (MTX & MSCs treated), apparent increase in the staining intensity of Safranin O stain of the cartilage ground substance was noticed especially in the upper zone in subgroup IIc (Fig. 5d ) and in the upper and lower zones in subgroup IId (Fig 5e) as compared to subgroups IIa and IIb.
Immunostaining for iNOS showed negative iNOS immunostaining of chondrocytes in the control group (Fig. 6a) . In subgroups IIa and IIb, many iNOS-positive chondrocytes were detected (Figs. 6b & 6c) , whereas, fewer iNOS-positive chondrocytes were seen in subgroups IIc and IId (Figs. 6d & 6e respectively) as compared to the untreated subgroups (IIa and IIb).
Morphometric and statistical results:
Cartilage thickness in the treated subgroups whether by MTX (subgroup IIc) or by BM-MSCs (subgroup IId) showed a non-significant change (P> 0.05) in comparison to the control group. On the contrary, untreated subgroups displayed a significant decrease (P<0.05) in comparison to the control group and treated subgroups ( 
DISCUSSION
Rheumatoid arthritis is an autoimmune disease of unknown etiology characterized by chronic progressive joint inflammation with subsequent cartilage and bone destruction [2] . Administration of MTX is a widely used method of treating RA. Methotrexate slows the rate of joint destruction through its inhibitory effects on the cascade of events initiated by inflammatory cytokines and subsequent joint-destructive enzymes [17] .
However, MTX treatment has no effect on regeneration of damaged articular cartilage. Thus, cartilage repair through cell therapy was a challenge. The regenerative potential of MSCs has been under intense investigation because of their ability for self-renewal and differentiation to reconstitute muscle, cartilage, or bone [18] .
In the current study, synovial membranes of the subgroup IIa (early RA), showed thick intimal lining, infiltration of the subintimal stroma with inflammatory cells, dilated congested blood vessels and villous formation. These findings were more profound in the progressive stage of the disease in subgroup IIb (late RA). The same findings were recorded by other investigators [19] , who suggested that RA is initiated in the synovial membrane where swelling and congestion lead to infiltration by immune cells followed by synovium thickening which is the major contributor to cartilage damage in RA.
These inflammatory cells were suggested to be due to increased levels of nitric oxide (NO) production from macrophage and endothelium leading to hypoxic environment that stimulates vessel dilatation and increased permeability, facilitating edema formation and immune cell extravasation [20] .
The relative increase of blood vessels in the subintimal stroma of the synovium in the RA subgroups might be explained on basis that inflammatory cells which infiltrate the subintimal stroma of the synovium are capable of induction of angiogenesis directly by producing angiogenic factors and/or indirectly through secreting cytokines that stimulated fibroblast to release angiogenic factors [20] .
In the present study, significant increase in the area percentage of collagen was detected in the synovium of RA subgroups compared to other groups. Similar results were reported by other studies [7, 21] but with no clear explanation of the mechanism for such increase. We assumed that RA fibroblast cells were not only activated to produce destructive enzymes but also were stimulated to produce collagen fibers in significant amounts.
In the current study, H&E stained cartilage sections showed signs of cellular and matrix degeneration in early and late RA. Cartilage damage in RA was suggested to be due to the destructive action of an inflammatory synovial pannus. Cartilage erosion usually starts at the sites of contact with pannus tissue which destroy cartilage by increasing proteolytic activity. Moreover, synovial fibroblasts could invade the articular cartilage at the affected joint or could secrete destructive enzymes in the synovial fluid [19] .
Mononuclear cellular infiltrate in the subintima of the synovium secrete certain factors as TNF-α, IL-1 and IL-6 which bound to chondrocytes receptors' leading to the release of matrix metallo-protineases (MMPs) that can degrade all component of the extracellular matrix, as well as inhibiting type II collagen production, hence enhancing cartilage degradation [22] . This could explain the fissuring of the matrix noticed in the present study in late RA (subgroup IIb) Furthermore, fissure formation could also be attributed to change in the type of the collagen in the articular cartilage from collagen type II to collagen type I leading to reduction in cartilage ability to store elastic energy [23] .
In the present study, chondrocytes were poorly arranged into layers in RA subgroups and were rather arranged into either clusters or isogenous groups. Sandell and Aigner, 2001 [24] stated that normal articular chondrocytes have no proliferative activity, in contrast, there is a low proliferative activity in osteoarthritic chondrocytes. They suggested that, the activity seen in osteoarthritic chondrocytes might be due to better access of proliferative factors to chondrocytes from the synovial fluid through fissuring or loosening of the collagen network, or due to the damage to the collagen matrix itself.
In this study, empty lacunae were detected in RA subgroups suggesting chondrocytes' death. Other studies have reported the apoptotic cell death as a dominant event in the degeneration of osteoarthritic cartilage [24, 25] . Nitric oxide (NO) was claimed to play a role in apoptosis of chondrocytes and synovial cells [26] . These apoptotic chondrocytes are not removed effectively from cartilage due to poor blood supply, and the products of cell death such as pyrophosphate and precipitated calcium may contribute to pathologic cartilage degradation [24] .
The significant decrease of the cartilage thickness in RA subgroups of the present study was in accordance with other studies [27, 28] . They attributed this to either invasion by proliferative fibrous tissue from the underlying bone or adjacent synovial tissues that leads to cartilage degradation.
Although MTX showed relative improvement of the structure of the cartilage and synovium structure in our study and other studies [29, 30] , due to its action that could prevent proliferation of monocytes, macrophages and synoviocytes, decrease synthesis of leukotriens in neutrophils, hold up cellular immunity and exert an anti-proliferative influence on endothelial cells. However, Kim et al., 2015 [17] considered poor organization of chondrocyte to be an adverse effect of MTX treatment.
The anti-inflammatory effects of MTX could be attributed to inhibition of proliferation of the cells responsible for synovial inflammation in RA; inhibition of the synthesis of potentially toxic compounds as mettallo-collangeolytic enzymes; reduction of macrophage recruitment and release of high concentrations of adenosine from cells and tissues [17] .
The remarkable improvement of the structure of the cartilage and synovium in the current study after MSCs treatment (subgroup IId) was also observed in other studies [6, 7] . This effect might be either due to differentiation to tissue cells and restoration of lost morphology and function, or secretion of a wide range of bioactive and growth factors such as: fibroblast growth factor, epidermal growth factor, plateletderived growth factor, and vascular endothelial growth factor which create a repair environment with anti-apoptotic effects, immune-regulatory function and the stimulation of endothelial progenitor cell proliferation [31] .
Hoogduijn et al., 2010 [32] added that MSCs could alter the cytokine secretion profile of immune cells such as decreasing TNF-α and interferon-γ secretion and increasing the secretion of suppressive cytokines (IL-4 and IL-10). This shift from a pro-inflammatory to a beneficial anti-inflammatory response was of therapeutic advantage.
Whether MSCs could perform its immunomodulatory effect in severe inflammatory conditions is a controversial issue, Klinker and Wei, 2015 [33] reported that the immunosuppressive capacity of MSCs was enhanced strongly under inflammatory conditions, and their differentiation capacity was preserved. On the contrary, Papadopoulou et al., 2012 [9] stated that MSCs lost their immune-modulatory properties when infused in inflammatory autoimmune arthritis as increased levels of TNF-α was shown to reverse the immune-suppressive properties of MSCs.
Staining of the cartilage ground substance in the present study by Safranin O, that stains proteoglycans in matrix, revealed significant low color density in the RA subgroup and MTX treated group compared to control and MSCs treated subgroups. Degraded cartilage matrix components are considered both as diagnostic marker of cartilage damage and as potential autoantigens in the induction and maintenance of RA synovial inflammation [34] Cartilage proteoglycans are capable of binding in a specific fashion to hyaluronic acid. Such associations produce large multimolecular aggregates, which are maintained within the extracellular matrix by a network of type II collagen [35] . Cartilage matrix molecules provide cushioning of the cartilage in the joint. Loss of ground substance in turn allow a greater susceptibility to damage from compressive forces and greater penetration of degenerative molecules leading to surface erosions [36] .
It is generally accepted that the degree of positive staining of Safranin O corresponds with the amount of proteoglycans in matrix [36, 37] . Moreover, reversible matrix staining loss is characteristic of the effects of proteolytic enzymes as metalloproteinases and aggrecanases which might be derived either from cartilage or from synovium, whereas, permanent matrix staining loss results from cell death (necrosis and apoptosis) coupled with inhibition of chondrocyte proliferation [28] .
In this view, Felson, 2006 [38] explained that degeneration of cartilage in osteoarthritis is characterized by two phases: a biosynthetic phase, during which the chondrocytes attempted to repair the damaged extracellular matrix; and a degradation phase, in which the activity of enzymes produced by the chondrocytes digests the matrix. Consequently, matrix synthesis is inhibited, and erosion of the cartilage is accelerated.
In MSCs treated subgroup, the consistent staining of the ground substance by Safranin O was attributed probably to the decrease in inflammatory cytokines as TNF-α and the release of anti-inflammatory substances which influence matrix turnover and inhibit proteoglycan degradation [5] . On the other hand, in MTX treated subgroup, there was a significant decrease in the color density of the ground substance reflecting depletion of proteoglycans.
Inducible nitric oxide synthase (iNOS) is a member of the nitric oxide synthase family. It is a pro-inflammatory marker which is known to increase in chronic inflammatory conditions and induce apoptosis, and matrix degradation through creating oxidative environments [14] . In the current study, statistical analysis of the mean number of iNOS positive chondrocytes revealed significant increase in number in RA subgroup, while a non-significant change was measured between MTX and MSCs treated groups.
Nitric oxide was found to cause hypoxia through inhibition of cell respiration by binding to cytochrome c oxidase, which in turn induces synovial angiogenesis that enables activated monocytes to invade the synovium and extend into the pannus, leading to bone and cartilage destruction. In addition, hypoxic media can induce degeneration of synoviocytes and chondrocytes, inhibition of collagen and proteoglycan synthesis and activation of matrix MMPs, which led to the articular cartilage degradation [26] .
The decrease in the number of iNOS positive chondrocytes in MTX and MSCs treated groups was attributed to their antiinflammatory and immunomodulatory effect as mentioned before.
In conclusion, our study showed that intra-articular injection of BM-MSCs was more effective than MTX in restoration of knee joint structure in a rat model of RA.
RECOMMENDATIONS:
Based on the results of the current study, intra articular stem cells' injection might represent a new promising therapy for the treatment of rheumatoid arthritis. Moreover, further studies on the effect of MSCs injection in early RA are recommended.
